Publicações

The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma

AuthID
P-00X-DRW

Author(s)

Bedke, J

Albiges, L

Capitanio, U

Giles, RH

Hora, M

Ljungberg, B

Marconi, L

Klatte, T

Volpe, A

Abu Ghanem, Y

Dabestani, S

Fernandez Pello, S

Hofmann, F

Kuusk, T

Tahbaz, R

Powles, T

Bex, A

Tipo de Documento

Article

Year published

2023

Publicado

in EUROPEAN UROLOGY, ISSN: 0302-2838

Volume: 83, Número: 1, Páginas: 10-+ (3)

Indexing

Wos^®

Scopus^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1016/j.eururo.2022.10.010

Pubmed: 36511268

SCOPUS: 2-s2.0-85140624777

Wos: WOS:000989352400004

Source Identifiers

ISSN: 0302-2838

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma

Links Úteis

Ajuda